ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04380	Osteoclast differentiation	36/371	134/7206	4.58232749903e-17
ko04060	Cytokine-cytokine receptor interaction	37/371	191/7206	1.18895071848e-12
ko04064	NF-kappa B signaling pathway	24/371	96/7206	4.964152092e-11
ko04621	NOD-like receptor signaling pathway	31/371	157/7206	5.30192643867e-11
ko05164	Influenza A	29/371	167/7206	5.3128781261e-09
ko04668	TNF signaling pathway	24/371	120/7206	6.58764932891e-09
ko04660	T cell receptor signaling pathway	24/371	124/7206	1.30241741344e-08
ko04650	Natural killer cell mediated cytotoxicity	20/371	97/7206	7.24928334524e-08
ko05321	Inflammatory bowel disease (IBD)	15/371	56/7206	8.37557901454e-08
ko04620	Toll-like receptor signaling pathway	20/371	100/7206	1.23676143908e-07
ko05144	Malaria	13/371	45/7206	2.35163465869e-07
ko04658	Th1 and Th2 cell differentiation	19/371	96/7206	3.05556875319e-07
ko04512	ECM-receptor interaction	17/371	79/7206	3.68971484713e-07
ko05161	Hepatitis B	26/371	173/7206	6.63129077283e-07
ko05140	Leishmaniasis	16/371	75/7206	9.2559066121e-07
ko05340	Primary immunodeficiency	10/371	30/7206	1.37988500669e-06
ko05133	Pertussis	17/371	87/7206	1.56224734348e-06
ko05323	Rheumatoid arthritis	17/371	89/7206	2.17680929324e-06
ko04622	RIG-I-like receptor signaling pathway	14/371	62/7206	2.17993975565e-06
ko04933	AGE-RAGE signaling pathway in diabetic complications	21/371	135/7206	4.61797285394e-06
ko05145	Toxoplasmosis	20/371	126/7206	5.69260319957e-06
ko05168	Herpes simplex infection	25/371	182/7206	5.83028134006e-06
ko04659	Th17 cell differentiation	18/371	106/7206	6.3597248187e-06
ko04610	Complement and coagulation cascades	15/371	79/7206	9.36306071364e-06
ko05152	Tuberculosis	25/371	187/7206	9.4930344506e-06
ko05162	Measles	19/371	120/7206	1.01399595388e-05
ko04630	Jak-STAT signaling pathway	20/371	132/7206	1.17105936221e-05
ko04623	Cytosolic DNA-sensing pathway	10/371	41/7206	3.0937240858e-05
ko04657	IL-17 signaling pathway	15/371	87/7206	3.1338428818e-05
ko05167	Kaposi's sarcoma-associated herpesvirus infection	24/371	191/7206	4.06694900206e-05
ko04210	Apoptosis	23/371	180/7206	4.51134709109e-05
ko05150	Staphylococcus aureus infection	9/371	36/7206	6.28323857412e-05
ko04672	Intestinal immune network for IgA production	9/371	37/7206	7.93109379107e-05
ko05166	HTLV-I infection	31/371	292/7206	0.000110603407733
ko04510	Focal adhesion	27/371	240/7206	0.000132191019436
ko04662	B cell receptor signaling pathway	14/371	88/7206	0.000141890418457
ko04666	Fc gamma R-mediated phagocytosis	17/371	122/7206	0.000154512699048
ko05131	Shigellosis	13/371	82/7206	0.000253227843063
ko05142	Chagas disease (American trypanosomiasis)	17/371	130/7206	0.000336095546909
ko04217	Necroptosis	21/371	178/7206	0.00037290236067
ko05034	Alcoholism	2/371	238/7206	0.000495203439338
ko04611	Platelet activation	19/371	163/7206	0.000835198133168
ko04062	Chemokine signaling pathway	22/371	201/7206	0.00087754141634
ko04670	Leukocyte transendothelial migration	18/371	151/7206	0.00102178264564
ko05330	Allograft rejection	6/371	24/7206	0.001090735207
ko05160	Hepatitis C	18/371	153/7206	0.00110990700423
ko05132	Salmonella infection	13/371	98/7206	0.00144699401054
ko04640	Hematopoietic cell lineage	10/371	64/7206	0.00145116247183
ko05016	Huntington's disease	2/371	215/7206	0.00147767717398
ko05418	Fluid shear stress and atherosclerosis	19/371	173/7206	0.00148012066783
ko05332	Graft-versus-host disease	5/371	18/7206	0.00172809208192
ko05222	Small cell lung cancer	12/371	89/7206	0.00189484447527
ko05120	Epithelial cell signaling in Helicobacter pylori infection	12/371	92/7206	0.00252119605151
ko05320	Autoimmune thyroid disease	6/371	29/7206	0.00309548352104
ko05200	Pathways in cancer	40/371	492/7206	0.0040224273677
ko05134	Legionellosis	10/371	74/7206	0.00436019361683
ko05146	Amoebiasis	12/371	99/7206	0.00465042198497
ko04724	Glutamatergic synapse	1/371	152/7206	0.00480651606667
ko04145	Phagosome	17/371	162/7206	0.00565871319347
ko04810	Regulation of actin cytoskeleton	24/371	264/7206	0.00634643266281
ko04713	Circadian entrainment	1/371	136/7206	0.0101344540936
ko04114	Oocyte meiosis	1/371	139/7206	0.0102800356644
ko04916	Melanogenesis	1/371	142/7206	0.0106959372249
ko05202	Transcriptional misregulation in cancer	18/371	188/7206	0.0107377005094
ko01200	Carbon metabolism	1/371	128/7206	0.0146788330774
ko04612	Antigen processing and presentation	9/371	77/7206	0.0168012461397
ko04550	Signaling pathways regulating pluripotency of stem cells	2/371	165/7206	0.0182970544844
ko04072	Phospholipase D signaling pathway	18/371	197/7206	0.020074441502
ko04940	Type I diabetes mellitus	5/371	32/7206	0.0225003444109
ko05143	African trypanosomiasis	5/371	32/7206	0.0225003444109
ko04144	Endocytosis	27/371	342/7206	0.0235921864042
ko04911	Insulin secretion	1/371	117/7206	0.0314830365541
ko05205	Proteoglycans in cancer	22/371	271/7206	0.0339740165386
ko05410	Hypertrophic cardiomyopathy (HCM)	10/371	100/7206	0.0373245498302
ko05212	Pancreatic cancer	9/371	83/7206	0.0383095082318
ko04932	Non-alcoholic fatty liver disease (NAFLD)	16/371	182/7206	0.0385609717124
ko04514	Cell adhesion molecules (CAMs)	12/371	130/7206	0.0430721370229
ko04917	Prolactin signaling pathway	9/371	87/7206	0.04399553072
ko04914	Progesterone-mediated oocyte maturation	1/371	104/7206	0.0440675101971
ko04727	GABAergic synapse	1/371	110/7206	0.0457539585079
ko04972	Pancreatic secretion	1/371	111/7206	0.0464108087932
ko04726	Serotonergic synapse	2/371	137/7206	0.0485013331024
ko00590	Arachidonic acid metabolism	6/371	52/7206	0.0494546280322